Exploring the Past and Current Landscape of Biomarker-Driven Clinical Trials Through Large Language Models First, we pretrained the encoder of a transformer-based network using a self-supervised ...

Semin Liver Dis. 2013;33(3):236-247. Focal nodular hyperplasia has no malignant potential and usually remains stable or decreases in size over time. Less than 20% of patients with FNH develop symptoms ...

Statewide first: UAMS is the first in Arkansas to offer histotripsy, a noninvasive ultrasound treatment for liver tumors. High success rates: Clinical trials showed a 95.5% success rate, with most ...

INDIANAPOLIS (WISH) — More than 40,000 people will be told they have liver cancer this year. Thirty thousand will die from the disease. It’s considered the leading cause of cancer deaths worldwide.

Researchers at Institute of Science Tokyo created a mouse model of the aggressive subtype of HCC and provided insights into its underlying molecular mechanism. Using these insights, they demonstrated ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates and overall survival, said Shaun P. McKenzie, MD, FACS, a surgical ...